SSG
RMD icon

Summit Securities Group’s ResMed RMD Stock Holding History

Summit Securities Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.39K Sell
24
-192
-89% -$47.8K ﹤0.01% 782
2025
Q4 		$52K Sell
216
-35
-14% -$8.95K 0.01% 605
2025
Q3 		$68.7K Buy
251
+153
+156% +$41.8K 0.01% 482
2025
Q2 		$25.3K Buy
+98
New +$23.4K ﹤0.01% 670
2024
Q3 		– Sell
-942
Closed -$180K – 821
2024
Q2 		$180K Buy
+942
New +$191K 0.03% 173
2024
Q1 		– Sell
-1
Closed – – 823
2023
Q4 		$0 Buy
+1
New +$154 ﹤0.01% 866
2023
Q3 		– Sell
-193
Closed -$42K – 953
2023
Q2 		$42K Sell
193
-98
-34% -$21.8K 0.01% 449
2023
Q1 		$64K Sell
291
-1,301
-82% -$282K 0.01% 377
2022
Q4 		$331K Buy
+1,592
New +$350K 0.01% 328
2022
Q3 		– Sell
-303
Closed -$64K – 1134
2022
Q2 		$64K Buy
303
+243
+405% +$51.7K 0.01% 496
2022
Q1 		$15K Buy
+60
New +$14.5K ﹤0.01% 765

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Summit Securities Group's RMD Position: Q1 2026 in Review

Summit Securities Group reduced its ResMed (RMD) stake by 89% in Q1 2026, selling an estimated $47.8K and leaving 24 shares worth $5.39K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Summit Securities Group first reported a position in RMD in Q1 2022 and has held it in 11 quarters since. The position peaked at $331K in Q4 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Summit Securities Group held 24 shares of ResMed worth $5.39K as of Q1 2026.
  • Summit Securities Group sold 192 ResMed shares in Q1 2026, an estimated $47.8K.
  • ResMed made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #782 holding.
  • Summit Securities Group first reported a position in ResMed in Q1 2022 and has held it in 11 quarters since.
  • Summit Securities Group's ResMed position peaked at $331K in Q4 2022.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.